Chen Xing Su

US Patent:

7018662, Mar 28, 2006

Filed:

Apr 17, 2002

Appl. No.:

10/124627

Inventors:

Chen Su - West Jordan UT, US
Jonathan William Fritz - Provo UT, US

Assignee:

Morinda, Inc. - Provo UT

International Classification:

A61K 35/78

US Classification:

424725

Abstract:

A method of preventing and treating various ailments and diseases by utilizing the Cox-2 selective inhibition characteristics of processed.

US Patent:

7048952, May 23, 2006

Filed:

May 16, 2003

Appl. No.:

10/439596

Inventors:

Scott Gerson - Brewster NY, US
Afa Kehaati Palu - Orem UT, US
Chen Su - West Jordan UT, US
Claude Jarakae Jensen - Cedar Hills UT, US
Stephen P. Story - Alpine UT, US
Robert V. Ogden - Cedar Hills UT, US

Assignee:

Morinda, Inc. - Provo UT

International Classification:

A61K 35/78

US Classification:

424725

Abstract:

The present invention relates to antifungal and antibacterial activity of processed products, as well as from various fractions of extracts from these processed products and the. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.

US Patent:

7070813, Jul 4, 2006

Filed:

Oct 31, 2002

Appl. No.:

10/285334

Inventors:

Claude Jarakae Jensen - Cedar Hills UT, US
Afa Kehaati Palu - Orem UT, US
Stephen P. Story - Alpine UT, US
Summer Jensen - Cedar Hills UT, US
Chen Su - West Jordan UT, US

Assignee:

Morinda, Inc. - Provo UT

International Classification:

A61K 35/78

US Classification:

424725

Abstract:

The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed product or an active ingredient there from, as obtained from the Indian Mulberry plant.

US Patent:

8025910, Sep 27, 2011

Filed:

May 10, 2007

Appl. No.:

11/746798

Inventors:

Chen Su - West Jordan UT, US
Afa K. Palu - American Fork UT, US
Brett J. West - Orem UT, US
Shixin Dong - Sandy UT, US
Claude Jarake Jensen - Cedar Hills UT, US
Stephen Story - Alpine UT, US

Assignee:

Tahitian Noni International, Inc. - Provo UT

International Classification:

A61K 36/746
A61K 36/00

US Classification:

424777, 424725

Abstract:

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.

US Patent:

8501245, Aug 6, 2013

Filed:

Mar 24, 2004

Appl. No.:

10/808872

Inventors:

Mian Ying Wang - Rockford IL, US
Chen Xing Su - West Jordan UT, US
Afa Kehaati Palu - Orem UT, US
Brett Justin West - Orem UT, US
Johannes Joseph Westendorf - Brernin, DE
Claude Jarakae Jensen - Cedar Hills UT, US
Stephen Paul Story - Alpine UT, US

Assignee:

Morinda, Inc. - Provo UT

International Classification:

A61K 36/00

US Classification:

424725

Abstract:

Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e. g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed products for a safe, pre-determined duration.

US Patent:

8535741, Sep 17, 2013

Filed:

Sep 27, 2011

Appl. No.:

13/246619

Inventors:

Bing-Nan Zhou - Shanghai, CN
Chen Su - West Jordan UT, US
Afa K. Palu - American Fork UT, US
Brett J. West - Cedar Hills UT, US
Shixin Deng - Lehi UT, US
Claude Jarakae Jensen - Cedar Hills UT, US
Stephen Story - Alpine UT, US

Assignee:

Morinda, Inc. - Provo UT

International Classification:

A61K 36/746
A61K 36/00

US Classification:

424777, 424725

Abstract:

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

US Patent:

8574642, Nov 5, 2013

Filed:

Nov 21, 2006

Appl. No.:

11/562224

Inventors:

Afa Kehaati Palu - American Fork UT, US
Chen Su - West Jordan UT, US
Brett West - Orem UT, US
Claude Jarake Jensen - Cedar Hills UT, US
Stephen Story - Alpine UT, US

Assignee:

Tahitian Noni International, Inc. - Provo UT

International Classification:

A61K 36/00

US Classification:

424777, 424725

Abstract:

The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processed based formulations.

US Patent:

20020068102, Jun 6, 2002

Filed:

Nov 29, 2001

Appl. No.:

09/997588

Inventors:

Chen Su - West Jordan UT, US
Claude Jensen - Cedar Hills UT, US
Stephen Story - Alpine UT, US

International Classification:

A61K035/78

US Classification:

424/765000, 424/777000

Abstract:

Providing and using a dietary supplement to reduce cellular damage within the human body. The dietary supplement includes reconstituted fruit juice from pure juice puree of French Polynesia, and may include other natural juices, such as a natural grape juice concentrate, a natural blueberry juice concentrate, and/or another natural juice concentrate. The dietary supplement includes a combination of compounds that work at the cellular level to increase the positive functionality of cells in the body, including cell regeneration and cell function, to increase the ability of cells to absorb and utilize nutrients, such as vitamins and minerals, and to. Furthermore, the dietary supplement scavenges lipid hydroperoxides and superoxide anion free radicals within the body to reduce cellular damage.